IDU Perspectives on the Design and Operation of North America's First Medically Supervised Injection Facility

REFERENCES

• Aceijas, C., & Rhodes, T. (2007). Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy, 18(5), 352–358.
   PubMed Web of Science ®Google Scholar
• Ahern, J., Stuber, J., & Galea, S. (2007). Stigma, discrimination, and the health of illicit drug users. Drug & Alcohol Dependence, 88, 188–196.
   PubMed Web of Science ®Google Scholar
• Allman, D., Myers, T., Schellenberg, J., Strike, C., Cockerill, R., & Cavalieri, W. (2007). Improving health and social care relationships for harm reduction. International Journal of Drug Policy, 18(3), 194–203.
   PubMed Web of Science ®Google Scholar
• Bastos, F. I., & Strathdee, S. A. (2000). Evaluating effectiveness of syringe exchange programmes: Current issues and future prospects. Social Science and Medicine, 51(12), 1771–1782.
   PubMed Web of Science ®Google Scholar
• Broadhead, R. S., Kerr, T. H., Grund, J.-P., & Altice, F. L. (2002). Safer injection facilities in North America: Their place in public policy and health initiatives. Journal of Drug Issues, 32(1), 329–355.
   Web of Science ®Google Scholar
• Cooper, H. F., Brady, J. E., Ciccarone, D., Tempalski, B., Gostnell, K., & Friedman, S. R. (2007). Nationwide increase in the number of hospitalizations for illicit injection drug use-related infective endocarditis. Clinical Infectious Diseases, 45(9), 1200–1203.
   PubMed Web of Science ®Google Scholar
• Fairbairn, N., Small, W., Shannon, K., Wood, E., & Kerr, T. (2008). Seeking refuge from violence in street-based drug scenes: Women's experiences in North America's first supervised injection facility. Social Science and Medicine, 67(5), 817–882.
   PubMed Web of Science ®Google Scholar
• Fischer, B., Turnbull, S., Poland, B., & Haydon, E. (2004). Drug use, risk and urban order: Examining supervised injection sites (SIS) as “governmentality.” International Journal of Drug Policy, 15, 357–365.
   Google Scholar
• Fry, C. L. (2002). Injecting drug user attitudes towards rules for supervised injecting rooms: Implications for uptake. International Journal of Drug Policy, 13, 471–476.
   Google Scholar
• Hedrich, D. (2004). European report on drug consumption rooms. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction.
   Google Scholar
• Hunt, N. (2006a). An overview of models of delivery of drug consumption rooms. York, UK: Joseph Rowntree Foundation.
   Google Scholar
• Hunt, N. (2006b). The evaluation literature on drug consumption rooms. York, UK: Joseph Rowntree Foundation.
   Google Scholar
• Kerr, T., Fairbairn, N., Tyndall, M. W., Marsh, D., Li, K., Montaner, J., (2007). Factors associated with non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug & Alcohol Dependence, 87(1), 39–45.
   PubMed Web of Science ®Google Scholar
• Kerr, T., Oleson, M., Tyndall, M. W., Montaner, J., & Wood, E. (2005). A description of a peer-run supervised injection site for injection drug users. Journal of Urban Health, 82(2), 267–275.
   PubMed Web of Science ®Google Scholar
• Kerr, T., Tyndall, M. W., Li, K., Montaner, J., & Wood, E. (2005). Safer injection facility use and syringe sharing in injection drug users. Lancet, 366, 316–318.
   PubMed Web of Science ®Google Scholar
• Kerr, T., Tyndall, M. W., Montaner, J., & Wood, E. (2004). Missed opportunities in the establishment of safer injection facilities: Reviewing the evidence to date. Paper presented at the 15th International Conference on Drug Related Harm, Melbourne, Australia.
   Google Scholar
• Kerr, T., Wood, E., Grafstein, E., Ishida, T., Shannon, K., Lai, C., (2004). High rates of primary care and emergency department use among injection drug users in Vancouver. Journal of Public Health, 27(1), 62–66.
   PubMed Web of Science ®Google Scholar
• Kimber, J., Dolan, K., van Beek, I., Hedrich, D., & Zurhold, H. (2003). Drug consumption facilities: an update since 2000. Drug & Alcohol Review, 22, 227–233.
   PubMed Web of Science ®Google Scholar
• Kimber, J., Dolan, K., & Wodak, A. (2005). Survey of drug consumption rooms: Service delivery and perceived health and amenity impact. Drug and Alcohol Review, 24, 21–24.
   PubMed Web of Science ®Google Scholar
• Kimber, J., Hickman, M., Degenhardt, L., van Beek, I., & Coulson, T. (2005). Estimating the size of the local IDU population using client visits to the Sydney Medically Supervised Injecting Centre. Paper presented at the 16th International Conference on the Reduction of Drug Related Harm, Belfast, Northern Ireland.
   Google Scholar
• McCoy, C. B., Metsch, L., Chitwood, D. D., & Miles, C. (2001). Drug use and barriers to use of health care services. Substance Use & Misuse, 36, 789–806.
   PubMed Web of Science ®Google Scholar
• MSIC Evaluation Committee. (2003). Final report of the evaluation of the Sydney medically supervised injecting centre. Sydney, Australia: Author.
   Google Scholar
• Neale, J., Sheard, L., & Tompkins, C. (2007). Factors that help injecting drug users to access and benefit from services: A qualitative study. Substance Abuse Treatment, Prevention and Policy, 2, 31.
   PubMed Web of Science ®Google Scholar
• O’Connell, J. M., Kerr, T., Li, K., Tyndall, M. W., Hogg, R. S., Montaner, J., (2005). Requiring help injecting independently predicts incident HIV infection among injection drug users. Journal of Acquired Immune Deficiency Syndrome, 40, 83–88.
   PubMed Web of Science ®Google Scholar
• Pearshouse, R., & Elliott, R. (2007). A helping hand: Legal issues related to assisted injection at supervised injection facilities. Toronto, ON, Canada: Canadian HIV/AIDS Legal Network.
   Google Scholar
• Petrar, S., Kerr, T., Tyndall, M. W., Zhang, R., Montaner, J. S., & Wood, E. (2007). Injection drug users’ perceptions regarding use of a medically supervised safer injecting facility. Addictive Behaviors, 32(5), 1088–1093.
   PubMed Web of Science ®Google Scholar
• Small, W., Rhodes, T., Wood, E., & Kerr, T. (2007). Public injection settings in Vancouver: Physical environment, social context and risk. International Journal of Drug Policy, 18, 27–36.
   PubMed Web of Science ®Google Scholar
• Tyndall, M. W., Craib, K. J., Currie, S., Li, K., O’Shaughnessy, M. V., & Schechter, M. T. (2001). Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndrome, 28(4), 351–357.
   PubMed Web of Science ®Google Scholar
• Tyndall, M. W., Kerr, T., Zhang, R., King, E., Montaner, J., & Wood, E. (2006). Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug & Alcohol Dependence, 83, 193–198.
   PubMed Web of Science ®Google Scholar
• Warner-Smith, M., Darke, S., & Day, C. (2002). Morbidity associated with non-fatal heroin overdose. Addiction, 97(8), 963–967.
   PubMed Web of Science ®Google Scholar
• Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J. S., (2004). Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal, 1(1), 9.
   PubMedGoogle Scholar
• Wood, E., Kerr, T., Small, W., Li, K., Marsh, D. C., Montaner, J. S., (2004) Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Canadian Medical Association Journal, 171(7), 731–734.
   PubMed Web of Science ®Google Scholar
• Wood, E., Tyndall, M. W., Montaner, J., & Kerr, T. (2006). Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Canadian Medical Association Journal, 175, 1399–1404.
   PubMed Web of Science ®Google Scholar
• Wood, E., Tyndall, M. W., Spittal, P. M., Li, K., Hogg, R. S., Montaner, J. S., (2002). Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS, 16(6), 941–943.
   PubMed Web of Science ®Google Scholar
• Wood, E., Tyndall, M. W., Stoltz, J., Small, W., Zhang, R., O’Connell, J., (2005). Safer injecting education for HIV prevention in a medically supervised safer injecting facility. International Journal of Drug Policy, 16, 281–284.
   Web of Science ®Google Scholar
• Wood, E., Tyndall, M. W., Zhang, R., Stoltz, J., Lai, C., Montaner, J. S., (2006). Attendance at supervised injecting facilities and use of detoxification services. New England Journal of Medicine, 354(23), 2512–2514.
   PubMed Web of Science ®Google Scholar
• Wood, E., Tyndall, M.W, Zhengou, Q., Zhang, R., Montaner, J., & Kerr, T. (2006). Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility. American Journal of Public Health, 96(5), 770–773.
   PubMed Web of Science ®Google Scholar